MedPath

JOHNS HOPKINS UNIVERSITY

🇳🇦Namibia
Ownership
-
Established
1876-01-01
Employees
19.4K
Market Cap
-
Website
https://www.jhu.edu/

Using Peer Mentors to Deliver Depression Care

Not Applicable
Completed
Conditions
Depression
Interventions
Behavioral: Meetings with peer mentors
First Posted Date
2014-10-10
Last Posted Date
2017-10-02
Lead Sponsor
Johns Hopkins University
Target Recruit Count
30
Registration Number
NCT02261818
Locations
🇺🇸

Johns Hopkins Bayview Medical Center, Baltimore, Maryland, United States

Assessing PA-824 for Tuberculosis (the APT Trial)

Phase 2
Completed
Conditions
Pulmonary Tuberculosis
Interventions
First Posted Date
2014-10-06
Last Posted Date
2023-07-18
Lead Sponsor
Johns Hopkins University
Target Recruit Count
157
Registration Number
NCT02256696
Locations
🇿🇦

University of Cape Town Lung Institute, Cape Town, South Africa

A Phase 1 Trial of Intrathecal Rituximab for Progressive Multiple Sclerosis Patients

Phase 1
Completed
Conditions
Primary Progressive Multiple Sclerosis
Secondary Progressive Multiple Sclerosis
Interventions
First Posted Date
2014-10-01
Last Posted Date
2017-08-30
Lead Sponsor
Johns Hopkins University
Target Recruit Count
8
Registration Number
NCT02253264
Locations
🇺🇸

The Johns Hopkins Hospital, Baltimore, Maryland, United States

Evaluation of Non-Inferiority of Two Fast Follower Nucleic Acid Amplification Tests

Completed
Conditions
Tuberculosis
Interventions
Other: Epistem Genedrive® and MolBio Truenat™
First Posted Date
2014-09-30
Last Posted Date
2017-12-12
Lead Sponsor
Johns Hopkins University
Target Recruit Count
504
Registration Number
NCT02252198
Locations
🇺🇸

Johns Hopkins University, Baltimore, Maryland, United States

Feasibility and Accuracy of a Novel Xpert Cartridge

Completed
Conditions
Tuberculosis
Interventions
Device: Investigational Xpert DST test
First Posted Date
2014-09-29
Last Posted Date
2018-08-22
Lead Sponsor
Johns Hopkins University
Target Recruit Count
401
Registration Number
NCT02251327

Environmental Control as Add-on Therapy in Childhood Asthma

Phase 2
Completed
Conditions
Asthma
Interventions
Other: Home Environmental Intervention
First Posted Date
2014-09-29
Last Posted Date
2019-11-20
Lead Sponsor
Johns Hopkins University
Target Recruit Count
155
Registration Number
NCT02251379
Locations
🇺🇸

Johns Hopkins University, Baltimore, Maryland, United States

NVAMD Satellite Study

Not Applicable
Completed
Conditions
Neovascular Age Related Macular Degeneration
Interventions
Procedure: Physician-guided diagnostic
First Posted Date
2014-09-29
Last Posted Date
2018-08-31
Lead Sponsor
Johns Hopkins University
Target Recruit Count
66
Registration Number
NCT02251366
Locations
🇺🇸

Wilmer Eye Institute, Lutherville, Maryland, United States

Intravenous Clonidine for Sedation in Infants and Children Who Are Mechanically Ventilated - Dosing Finding Study

Phase 1
Completed
Conditions
Mechanical Ventilation Complication
Interventions
Drug: intermittent IV CLON
First Posted Date
2014-09-25
Last Posted Date
2021-03-01
Lead Sponsor
Johns Hopkins University
Target Recruit Count
14
Registration Number
NCT02249039
Locations
🇺🇸

Johns Hopkins Hospital, Baltimore, Maryland, United States

Cell-Based Approaches For Modeling and Treating Ataxia-Telangiectasia

Not Applicable
Terminated
Conditions
Ataxia-Telangiectasia (A-T)
Interventions
Other: Carrier patients iPS cell line
Other: A-T iPS cell line
First Posted Date
2014-09-22
Last Posted Date
2019-03-19
Lead Sponsor
Johns Hopkins University
Target Recruit Count
6
Registration Number
NCT02246491
Locations
🇺🇸

SKCCC at Johns Hopkins, Baltimore, Maryland, United States

Effects of Psilocybin-facilitated Experience on the Psychology and Effectiveness of Professional Leaders in Religion

Phase 1
Completed
Conditions
Healthy
Interventions
First Posted Date
2014-09-18
Last Posted Date
2024-06-18
Lead Sponsor
Johns Hopkins University
Target Recruit Count
24
Registration Number
NCT02243813
Locations
🇺🇸

Behavioral Biology Research Center, Johns Hopkins Bayview, Baltimore, Maryland, United States

© Copyright 2025. All Rights Reserved by MedPath